ID   GNAQ_HUMAN              Reviewed;         359 AA.
AC   P50148; O15108; Q13462; Q6NT27; Q92471; Q9BZB9;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   07-JUL-2009, sequence version 4.
DT   05-OCT-2016, entry version 163.
DE   RecName: Full=Guanine nucleotide-binding protein G(q) subunit alpha;
DE   AltName: Full=Guanine nucleotide-binding protein alpha-q;
GN   Name=GNAQ; Synonyms=GAQ;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8825633; DOI=10.1006/geno.1995.1267;
RA   Dong Q., Shenker A., Way J., Haddad B.R., Lin K., Hughes M.R.,
RA   McBride W.O., Spiegel A.M., Battey J.;
RT   "Molecular cloning of human G alpha q cDNA and chromosomal
RT   localization of the G alpha q gene (GNAQ) and a processed
RT   pseudogene.";
RL   Genomics 30:470-475(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Prostate;
RX   PubMed=8664309; DOI=10.1016/0005-2736(96)00039-9;
RA   Chen B., Leverette R.D., Schwinn D.A., Kwatra M.M.;
RT   "Human G(alpha q): cDNA and tissue distribution.";
RL   Biochim. Biophys. Acta 1281:125-128(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8836152; DOI=10.1042/bj3181023;
RA   Johnson G.J., Leis L.A., Dunlop P.C.;
RT   "Specificity of G alpha q and G alpha 11 gene expression in platelets
RT   and erythrocytes. Expressions of cellular differentiation and species
RT   differences.";
RL   Biochem. J. 318:1023-1031(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=9700850; DOI=10.1016/S0049-3848(98)00071-1;
RA   Gabbeta J., Dhanasekaran N., Rao A.K.;
RT   "G alpha q cDNA sequence from human platelets.";
RL   Thromb. Res. 91:29-32(1998).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Bai X.H., Acharya R., Rivera C., Murtagh J.J.;
RT   "Nucleotide sequence of human Gq guanine nucleotide binding protein.";
RL   Submitted (JUN-1997) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Puhl H.L. III, Ikeda S.R., Aronstam R.S.;
RT   "cDNA clones of human proteins involved in signal transduction
RT   sequenced by the Guthrie cDNA resource center (www.cdna.org).";
RL   Submitted (MAR-2002) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 80-235.
RC   TISSUE=Brain cortex;
RX   PubMed=1333286; DOI=10.1016/0006-3223(92)90070-G;
RA   Lesch K.-P., Manji H.K.;
RT   "Signal-transducing G proteins and antidepressant drugs: evidence for
RT   modulation of alpha subunit gene expression in rat brain.";
RL   Biol. Psychiatry 32:549-579(1992).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 244-337.
RC   TISSUE=Hematopoietic;
RX   PubMed=7492305; DOI=10.1042/bj3120151;
RA   Thomas C.P., Dunn M.J., Mattera R.;
RT   "Ca2+ signalling in K562 human erythroleukaemia cells: effect of
RT   dimethyl sulphoxide and role of G-proteins in thrombin- and
RT   thromboxane A2-activated pathways.";
RL   Biochem. J. 312:151-158(1995).
RN   [12]
RP   INTERACTION WITH SLC9A3R1.
RX   PubMed=12193606; DOI=10.1074/jbc.M207910200;
RA   Rochdi M.D., Watier V., La Madeleine C., Nakata H., Kozasa T.,
RA   Parent J.-L.;
RT   "Regulation of GTP-binding protein alpha q (Galpha q) signaling by the
RT   ezrin-radixin-moesin-binding phosphoprotein-50 (EBP50).";
RL   J. Biol. Chem. 277:40751-40759(2002).
RN   [13]
RP   INTERACTION WITH PECAM1.
RX   PubMed=18672896; DOI=10.1021/bi8003846;
RA   Yeh J.C., Otte L.A., Frangos J.A.;
RT   "Regulation of G protein-coupled receptor activities by the platelet-
RT   endothelial cell adhesion molecule, PECAM-1.";
RL   Biochemistry 47:9029-9039(2008).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   TISSUE SPECIFICITY.
RX   PubMed=21923740; DOI=10.1111/j.1365-3083.2011.02635.x;
RA   Wang Y., Li Y., He Y., Sun Y., Sun W., Xie Q., Yin G., Du Y., Wang L.,
RA   Shi G.;
RT   "Expression of G protein alphaq subunit is decreased in lymphocytes
RT   from rheumatoid arthritis patients and is correlated with disease
RT   activity.";
RL   Scand. J. Immunol. 75:203-209(2012).
RN   [16]
RP   INVOLVEMENT IN CMC, VARIANT SWS GLN-183, AND CHARACTERIZATION OF
RP   VARIANT SWS GLN-183.
RX   PubMed=23656586; DOI=10.1056/NEJMoa1213507;
RA   Shirley M.D., Tang H., Gallione C.J., Baugher J.D., Frelin L.P.,
RA   Cohen B., North P.E., Marchuk D.A., Comi A.M., Pevsner J.;
RT   "Sturge-Weber syndrome and port-wine stains caused by somatic mutation
RT   in GNAQ.";
RL   N. Engl. J. Med. 368:1971-1979(2013).
RN   [17]
RP   DEAMIDATION AT GLN-209 (MICROBIAL INFECTION).
RX   PubMed=24141704; DOI=10.1038/nsmb.2688;
RA   Jank T., Bogdanovic X., Wirth C., Haaf E., Spoerner M., Boehmer K.E.,
RA   Steinemann M., Orth J.H., Kalbitzer H.R., Warscheid B., Hunte C.,
RA   Aktories K.;
RT   "A bacterial toxin catalyzing tyrosine glycosylation of Rho and
RT   deamidation of Gq and Gi proteins.";
RL   Nat. Struct. Mol. Biol. 20:1273-1280(2013).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [20]
RP   CHARACTERIZATION OF VARIANT LEU-209.
RX   PubMed=19078957; DOI=10.1038/nature07586;
RA   Van Raamsdonk C.D., Bezrookove V., Green G., Bauer J., Gaugler L.,
RA   O'Brien J.M., Simpson E.M., Barsh G.S., Bastian B.C.;
RT   "Frequent somatic mutations of GNAQ in uveal melanoma and blue
RT   naevi.";
RL   Nature 457:599-602(2009).
RN   [21]
RP   VARIANT GLN-183.
RX   PubMed=22307269; DOI=10.1007/s00401-012-0948-x;
RA   Murali R., Wiesner T., Rosenblum M.K., Bastian B.C.;
RT   "GNAQ and GNA11 mutations in melanocytomas of the central nervous
RT   system.";
RL   Acta Neuropathol. 123:457-459(2012).
CC   -!- FUNCTION: Guanine nucleotide-binding proteins (G proteins) are
CC       involved as modulators or transducers in various transmembrane
CC       signaling systems. Regulates B-cell selection and survival and is
CC       required to prevent B-cell-dependent autoimmunity. Regulates
CC       chemotaxis of BM-derived neutrophils and dendritic cells (in
CC       vitro) (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: G proteins are composed of 3 units; alpha, beta and
CC       gamma. The alpha chain contains the guanine nucleotide binding
CC       site. Binds SLC9A3R1. Forms a complex with PECAM1 and BDKRB2.
CC       Interacts with PECAM1. {ECO:0000269|PubMed:12193606,
CC       ECO:0000269|PubMed:18672896}.
CC   -!- INTERACTION:
CC       P49407:ARRB1; NbExp=2; IntAct=EBI-3909604, EBI-743313;
CC       P10276:RARA; NbExp=4; IntAct=EBI-3909604, EBI-413374;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Membrane
CC       {ECO:0000250}. Nucleus membrane {ECO:0000250}. Note=Colocalizes
CC       with the adrenergic receptors, ADREN1A and ADREN1B, at the nuclear
CC       membrane of cardiac myocytes. {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in ovary, prostate,
CC       testis and colon. Down-regulated in the peripheral blood
CC       lymphocytes (PBLs) of rheumatoid arthritis patients (at protein
CC       level). {ECO:0000269|PubMed:21923740, ECO:0000269|PubMed:8664309}.
CC   -!- PTM: (Microbial infection) Deamidated at Gln-209 by Photorhabdus
CC       asymbiotica toxin PAU_02230, blocking GTP hydrolysis of
CC       heterotrimeric GNAQ or GNA11 and G-alphai (GNAI1, GNAI2 or GNAI3)
CC       proteins, thereby activating RhoA. {ECO:0000269|PubMed:24141704}.
CC   -!- DISEASE: Capillary malformations, congenital (CMC) [MIM:163000]: A
CC       form of vascular malformations that are present from birth, tend
CC       to grow with the individual, do not regress spontaneously, and
CC       show normal rates of endothelial cell turnover. Capillary
CC       malformations are distinct from capillary hemangiomas, which are
CC       highly proliferative lesions that appear shortly after birth and
CC       show rapid growth, slow involution, and endothelial
CC       hypercellularity. {ECO:0000269|PubMed:23656586}. Note=The disease
CC       is caused by mutations affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Sturge-Weber syndrome (SWS) [MIM:185300]: A syndrome
CC       characterized by an intracranial vascular anomaly, leptomeningeal
CC       angiomatosis, most often involving the occipital and posterior
CC       parietal lobes. The most common features are facial cutaneous
CC       vascular malformations (port-wine stains), seizures, and glaucoma.
CC       Stasis results in ischemia underlying the leptomeningeal
CC       angiomatosis, leading to calcification and laminar cortical
CC       necrosis. The clinical course is highly variable and some children
CC       experience intractable seizures, mental retardation, and recurrent
CC       stroke-like episodes. {ECO:0000269|PubMed:23656586}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: Belongs to the G-alpha family. G(q) subfamily.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/GNAQID43280ch9q21.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U40038; AAC50363.1; -; mRNA.
DR   EMBL; U43083; AAB06875.1; -; mRNA.
DR   EMBL; L76256; AAB39498.1; -; mRNA.
DR   EMBL; AF329284; AAG61117.1; -; mRNA.
DR   EMBL; AF011496; AAB64301.1; -; mRNA.
DR   EMBL; AF493896; AAM12610.1; -; mRNA.
DR   EMBL; AL160268; CAI12198.1; -; Genomic_DNA.
DR   EMBL; AL160278; CAI12198.1; JOINED; Genomic_DNA.
DR   EMBL; AL355535; CAI12198.1; JOINED; Genomic_DNA.
DR   EMBL; AL355535; CAI14669.1; -; Genomic_DNA.
DR   EMBL; AL160268; CAI14669.1; JOINED; Genomic_DNA.
DR   EMBL; AL160278; CAI14669.1; JOINED; Genomic_DNA.
DR   EMBL; AL160278; CAI15999.1; -; Genomic_DNA.
DR   EMBL; AL160268; CAI15999.1; JOINED; Genomic_DNA.
DR   EMBL; AL355535; CAI15999.1; JOINED; Genomic_DNA.
DR   EMBL; CH471089; EAW62607.1; -; Genomic_DNA.
DR   EMBL; BC057777; AAH57777.1; -; mRNA.
DR   EMBL; BC067850; AAH67850.1; -; mRNA.
DR   EMBL; BC069520; AAH69520.1; -; mRNA.
DR   EMBL; BC075096; AAH75096.1; -; mRNA.
DR   EMBL; BC075097; AAH75097.1; -; mRNA.
DR   EMBL; L40629; AAA99950.1; -; mRNA.
DR   CCDS; CCDS6658.1; -.
DR   PIR; S59635; S59635.
DR   PIR; S71963; S71963.
DR   RefSeq; NP_002063.2; NM_002072.4.
DR   UniGene; Hs.269782; -.
DR   UniGene; Hs.594695; -.
DR   ProteinModelPortal; P50148; -.
DR   SMR; P50148; 13-354.
DR   BioGrid; 109038; 79.
DR   DIP; DIP-41652N; -.
DR   IntAct; P50148; 11.
DR   MINT; MINT-262439; -.
DR   STRING; 9606.ENSP00000286548; -.
DR   ChEMBL; CHEMBL3286079; -.
DR   iPTMnet; P50148; -.
DR   SwissPalm; P50148; -.
DR   DMDM; 251757492; -.
DR   EPD; P50148; -.
DR   MaxQB; P50148; -.
DR   PaxDb; P50148; -.
DR   PeptideAtlas; P50148; -.
DR   PRIDE; P50148; -.
DR   DNASU; 2776; -.
DR   Ensembl; ENST00000286548; ENSP00000286548; ENSG00000156052.
DR   GeneID; 2776; -.
DR   KEGG; hsa:2776; -.
DR   UCSC; uc004akw.5; human.
DR   CTD; 2776; -.
DR   GeneCards; GNAQ; -.
DR   HGNC; HGNC:4390; GNAQ.
DR   HPA; CAB010036; -.
DR   HPA; HPA048886; -.
DR   MalaCards; GNAQ; -.
DR   MIM; 163000; phenotype.
DR   MIM; 185300; phenotype.
DR   MIM; 600998; gene.
DR   neXtProt; NX_P50148; -.
DR   Orphanet; 624; Familial multiple nevi flammei.
DR   Orphanet; 3205; Sturge-Weber syndrome.
DR   PharmGKB; PA174; -.
DR   eggNOG; KOG0085; Eukaryota.
DR   eggNOG; ENOG410XNVQ; LUCA.
DR   GeneTree; ENSGT00760000118851; -.
DR   HOGENOM; HOG000038729; -.
DR   HOVERGEN; HBG063184; -.
DR   InParanoid; P50148; -.
DR   KO; K04634; -.
DR   OMA; FIKELWE; -.
DR   OrthoDB; EOG091G0VUT; -.
DR   PhylomeDB; P50148; -.
DR   TreeFam; TF300673; -.
DR   Reactome; R-HSA-399997; Acetylcholine regulates insulin secretion.
DR   Reactome; R-HSA-416476; G alpha (q) signalling events.
DR   Reactome; R-HSA-418592; ADP signalling through P2Y purinoceptor 1.
DR   Reactome; R-HSA-428930; Thromboxane signalling through TP receptor.
DR   Reactome; R-HSA-434316; Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion.
DR   Reactome; R-HSA-456926; Thrombin signalling through proteinase activated receptors (PARs).
DR   SignaLink; P50148; -.
DR   SIGNOR; P50148; -.
DR   ChiTaRS; GNAQ; human.
DR   GeneWiki; GNAQ; -.
DR   GenomeRNAi; 2776; -.
DR   PRO; PR:P50148; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000156052; -.
DR   CleanEx; HS_GNAQ; -.
DR   ExpressionAtlas; P50148; baseline and differential.
DR   Genevisible; P50148; HS.
DR   GO; GO:0044297; C:cell body; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; TAS:ProtInc.
DR   GO; GO:0030425; C:dendrite; IEA:Ensembl.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005765; C:lysosomal membrane; IDA:UniProtKB.
DR   GO; GO:0031965; C:nuclear membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0001750; C:photoreceptor outer segment; ISS:AgBase.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005096; F:GTPase activator activity; IDA:UniProtKB.
DR   GO; GO:0003924; F:GTPase activity; TAS:Reactome.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004871; F:signal transducer activity; IEA:UniProtKB-KW.
DR   GO; GO:0031826; F:type 2A serotonin receptor binding; IBA:GO_Central.
DR   GO; GO:0001508; P:action potential; IBA:GO_Central.
DR   GO; GO:0007202; P:activation of phospholipase C activity; TAS:ProtInc.
DR   GO; GO:0007189; P:adenylate cyclase-activating G-protein coupled receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0007596; P:blood coagulation; TAS:ProtInc.
DR   GO; GO:0048066; P:developmental pigmentation; IEA:Ensembl.
DR   GO; GO:0042733; P:embryonic digit morphogenesis; IEA:Ensembl.
DR   GO; GO:0009649; P:entrainment of circadian clock; ISS:AgBase.
DR   GO; GO:0021884; P:forebrain neuron development; IEA:Ensembl.
DR   GO; GO:0007213; P:G-protein coupled acetylcholine receptor signaling pathway; ISS:AgBase.
DR   GO; GO:0007215; P:glutamate receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0007507; P:heart development; IEA:Ensembl.
DR   GO; GO:0042711; P:maternal behavior; IEA:Ensembl.
DR   GO; GO:0006469; P:negative regulation of protein kinase activity; IMP:BHF-UCL.
DR   GO; GO:0016322; P:neuron remodeling; IEA:Ensembl.
DR   GO; GO:0060158; P:phospholipase C-activating dopamine receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0007603; P:phototransduction, visible light; ISS:AgBase.
DR   GO; GO:0030168; P:platelet activation; TAS:Reactome.
DR   GO; GO:0009791; P:post-embryonic development; IEA:Ensembl.
DR   GO; GO:0050821; P:protein stabilization; IMP:BHF-UCL.
DR   GO; GO:0035412; P:regulation of catenin import into nucleus; IMP:BHF-UCL.
DR   GO; GO:0045634; P:regulation of melanocyte differentiation; IEA:Ensembl.
DR   GO; GO:0001501; P:skeletal system development; IEA:Ensembl.
DR   Gene3D; 1.10.400.10; -; 1.
DR   Gene3D; 3.40.50.300; -; 2.
DR   InterPro; IPR000654; Gprotein_alpha_Q.
DR   InterPro; IPR001019; Gprotein_alpha_su.
DR   InterPro; IPR011025; GproteinA_insert.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR10218; PTHR10218; 1.
DR   Pfam; PF00503; G-alpha; 1.
DR   PRINTS; PR00318; GPROTEINA.
DR   PRINTS; PR00442; GPROTEINAQ.
DR   SMART; SM00275; G_alpha; 1.
DR   SUPFAM; SSF47895; SSF47895; 1.
DR   SUPFAM; SSF52540; SSF52540; 2.
PE   1: Evidence at protein level;
KW   ADP-ribosylation; Complete proteome; Disease mutation; GTP-binding;
KW   Lipoprotein; Magnesium; Membrane; Metal-binding; Nucleotide-binding;
KW   Nucleus; Palmitate; Polymorphism; Reference proteome; Transducer.
FT   CHAIN         1    359       Guanine nucleotide-binding protein G(q)
FT                                subunit alpha.
FT                                /FTId=PRO_0000203760.
FT   NP_BIND      46     53       GTP. {ECO:0000250|UniProtKB:P63096}.
FT   NP_BIND     180    186       GTP. {ECO:0000250}.
FT   NP_BIND     205    209       GTP. {ECO:0000250|UniProtKB:P63096}.
FT   NP_BIND     274    277       GTP. {ECO:0000250|UniProtKB:P63096}.
FT   METAL        53     53       Magnesium. {ECO:0000250}.
FT   METAL       186    186       Magnesium. {ECO:0000250}.
FT   BINDING     331    331       GTP; via amide nitrogen. {ECO:0000250}.
FT   MOD_RES     183    183       ADP-ribosylarginine; by cholera toxin.
FT                                {ECO:0000250}.
FT   MOD_RES     209    209       Deamidated glutamine; by Photorhabdus
FT                                PAU_02230. {ECO:0000269|PubMed:24141704}.
FT   LIPID         9      9       S-palmitoyl cysteine. {ECO:0000250}.
FT   LIPID        10     10       S-palmitoyl cysteine. {ECO:0000250}.
FT   VARIANT     183    183       R -> Q (in SWS; found as somatic mosaic
FT                                mutation in CMC; also found in
FT                                melanocytomas sample; somatic mutation;
FT                                shows significant activation of EPHB2
FT                                compared to control; dbSNP:rs397514698).
FT                                {ECO:0000269|PubMed:22307269,
FT                                ECO:0000269|PubMed:23656586}.
FT                                /FTId=VAR_067270.
FT   VARIANT     209    209       Q -> L (found in blue naevi and uveal
FT                                melanoma samples; somatic mutation;
FT                                constitutive activation;
FT                                dbSNP:rs121913492).
FT                                {ECO:0000269|PubMed:19078957}.
FT                                /FTId=VAR_067271.
FT   VARIANT     355    355       E -> D (in dbSNP:rs1059531).
FT                                /FTId=VAR_059319.
FT   CONFLICT      4      4       E -> D (in Ref. 5; AAB64301).
FT                                {ECO:0000305}.
FT   CONFLICT     28     29       QL -> HV (in Ref. 1; AAC50363).
FT                                {ECO:0000305}.
FT   CONFLICT     92     92       R -> T (in Ref. 5; AAB64301).
FT                                {ECO:0000305}.
FT   CONFLICT    103    103       Y -> C (in Ref. 5; AAB64301).
FT                                {ECO:0000305}.
FT   CONFLICT    324    324       I -> N (in Ref. 2; AAB06875).
FT                                {ECO:0000305}.
FT   CONFLICT    337    337       I -> V (in Ref. 5; AAB64301).
FT                                {ECO:0000305}.
FT   CONFLICT    358    358       L -> A (in Ref. 3; AAB39498).
FT                                {ECO:0000305}.
SQ   SEQUENCE   359 AA;  42142 MW;  6F69C4F617DFA7C7 CRC64;
     MTLESIMACC LSEEAKEARR INDEIERQLR RDKRDARREL KLLLLGTGES GKSTFIKQMR
     IIHGSGYSDE DKRGFTKLVY QNIFTAMQAM IRAMDTLKIP YKYEHNKAHA QLVREVDVEK
     VSAFENPYVD AIKSLWNDPG IQECYDRRRE YQLSDSTKYY LNDLDRVADP AYLPTQQDVL
     RVRVPTTGII EYPFDLQSVI FRMVDVGGQR SERRKWIHCF ENVTSIMFLV ALSEYDQVLV
     ESDNENRMEE SKALFRTIIT YPWFQNSSVI LFLNKKDLLE EKIMYSHLVD YFPEYDGPQR
     DAQAAREFIL KMFVDLNPDS DKIIYSHFTC ATDTENIRFV FAAVKDTILQ LNLKEYNLV
//
